Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 5/2020

01-10-2020 | Magnetic Resonance Imaging | Case Report

Neoplastic meningitis due to colorectal cancer

Authors: Kaoru Kidate, Hironori Kobayashi, Katsunari Miyamoto, Yoshihiro Sakashita, Motoki Ninomiya, Yujiro Yokoyama, Yasushi Hashimoto, Kazuhiro Toyota, Fumio Shimamoto

Published in: Clinical Journal of Gastroenterology | Issue 5/2020

Login to get access

Abstract

Herein, we describe a rare case of neoplastic meningitis in a 54-year-old male with a history of colorectal cancer. He first noticed a loss of sensation in his left thigh along with back pain. Magnetic resonance imaging showed a tumor lesion in the cauda equina. The tumor was surgically resected and pathologically diagnosed as a metastatic tumor of the descending colon cancer for which he had undergone resection a year earlier. The patient was treated with chemotherapy using capecitabine, oxaliplatin, and cetuximab. During chemotherapy, his tumor markers decreased and magnetic resonance imaging showed tumor shrinkage, but he became aware of neurological symptoms such as hearing loss, tinnitus, and headache. The patient’s condition suddenly worsened during the 5th course of chemotherapy and he died 5 months after the diagnosis. Neoplastic meningitis occurs in 4–15% of patients with solid tumors, but it is rarely seen in colorectal cancer. It should be considered when a patient with a history of cancer has back pain or neurological symptoms. The progression of neoplastic meningitis is fast and it has a poor prognosis. Diagnosis in the early stages is important to prevent progression of neurological symptoms and to provide the most effective treatment.
Literature
1.
go back to reference Kawaji H, Tokuyama T, Namba H. Spinal dissemination. Nippon Rinsho. 2016;74:459–63. Kawaji H, Tokuyama T, Namba H. Spinal dissemination. Nippon Rinsho. 2016;74:459–63.
2.
go back to reference Lombardi G, Zustovich F, Farina P, et al. Neoplastic meningitis from solid tumors: new diagnostic and therapeutic approaches. Oncologist. 2011;16:1175–88.CrossRef Lombardi G, Zustovich F, Farina P, et al. Neoplastic meningitis from solid tumors: new diagnostic and therapeutic approaches. Oncologist. 2011;16:1175–88.CrossRef
3.
go back to reference Kato H, Emura S, Takashima T, et al. Gadolinium-enhanced magnetic resonance imaging of meningeal carcinomatosis in colon cancer. Tohoku J Exp Med. 1995;176:121–6.CrossRef Kato H, Emura S, Takashima T, et al. Gadolinium-enhanced magnetic resonance imaging of meningeal carcinomatosis in colon cancer. Tohoku J Exp Med. 1995;176:121–6.CrossRef
4.
go back to reference Mammoser AG, Groves MD. Biology and therapy of neoplastic meningitis. Curr Oncol Rep. 2010;12:41–9.CrossRef Mammoser AG, Groves MD. Biology and therapy of neoplastic meningitis. Curr Oncol Rep. 2010;12:41–9.CrossRef
5.
go back to reference Grewal J, Saria MG, Kesari S. Novel approaches to treating leptomeningeal metastases. J Neurooncol. 2012;106:225–34.CrossRef Grewal J, Saria MG, Kesari S. Novel approaches to treating leptomeningeal metastases. J Neurooncol. 2012;106:225–34.CrossRef
6.
go back to reference Japanese Society for Cancer of the Colon and Rectum. Japanese classification of colorectal, appendiceal, and anal carcinoma. 9th ed. Tokyo: Kanehara & Co.; 2019. Japanese Society for Cancer of the Colon and Rectum. Japanese classification of colorectal, appendiceal, and anal carcinoma. 9th ed. Tokyo: Kanehara & Co.; 2019.
7.
go back to reference Chamberlain MC, Nolan C, Abrey LE. Leukemic and lymphomatous meningitis: incidence, prognosis and treatment. J Neurooncol. 2005;75:71–83.CrossRef Chamberlain MC, Nolan C, Abrey LE. Leukemic and lymphomatous meningitis: incidence, prognosis and treatment. J Neurooncol. 2005;75:71–83.CrossRef
8.
go back to reference Clarke JL, Perez HR, Jacks LM, et al. Leptomeningeal metastases in the MRI era. Neurology. 2010;74:1449–544.CrossRef Clarke JL, Perez HR, Jacks LM, et al. Leptomeningeal metastases in the MRI era. Neurology. 2010;74:1449–544.CrossRef
9.
go back to reference Glesinner B, Chamberlain MC. Neoplastic meningitis. Lancet Neurol. 2006;5:443–52.CrossRef Glesinner B, Chamberlain MC. Neoplastic meningitis. Lancet Neurol. 2006;5:443–52.CrossRef
10.
11.
go back to reference Glantz MJ, Cole BF, Glantz LK, et al. Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer. 1998;82:733–9.CrossRef Glantz MJ, Cole BF, Glantz LK, et al. Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer. 1998;82:733–9.CrossRef
12.
go back to reference Morris D, Groves MD. New strategies in the management of leptomeningeal metastases. Arch Neurol. 2010;67:305–12. Morris D, Groves MD. New strategies in the management of leptomeningeal metastases. Arch Neurol. 2010;67:305–12.
13.
go back to reference Grossman SA, Krabak MJ. Leptomeningeal carcinomatosis. Cancer Treat Rev. 1999;25:103–19.CrossRef Grossman SA, Krabak MJ. Leptomeningeal carcinomatosis. Cancer Treat Rev. 1999;25:103–19.CrossRef
14.
go back to reference Ushio Y, Shimizu K, Aragaki Y, et al. Alteration of blood-CSF barrier by tumor invasion into the meninges. J Neurosurg. 1981;55:445–9.CrossRef Ushio Y, Shimizu K, Aragaki Y, et al. Alteration of blood-CSF barrier by tumor invasion into the meninges. J Neurosurg. 1981;55:445–9.CrossRef
15.
go back to reference Nakagawa H, Fujita T, Kubo S, et al. Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patient with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor. Cancer Chemother Pharmacol. 1996;37:317–26.CrossRef Nakagawa H, Fujita T, Kubo S, et al. Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patient with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor. Cancer Chemother Pharmacol. 1996;37:317–26.CrossRef
16.
go back to reference Giglio P, Tremont-Lukats IW, Groves MD. Response of neoplastic meningitis from solid tumor to oral capecitabine. J Neurooncol. 2003;65:167–72.CrossRef Giglio P, Tremont-Lukats IW, Groves MD. Response of neoplastic meningitis from solid tumor to oral capecitabine. J Neurooncol. 2003;65:167–72.CrossRef
17.
go back to reference Tham YL, Hinckley L, Teh BS, et al. Long- term clinical response in leptomeningeal metastases from breast cancer treated with capecitabine monotherapy: a case report. Clin Breast Cancer. 2006;7:164–6.CrossRef Tham YL, Hinckley L, Teh BS, et al. Long- term clinical response in leptomeningeal metastases from breast cancer treated with capecitabine monotherapy: a case report. Clin Breast Cancer. 2006;7:164–6.CrossRef
18.
go back to reference Paydas S, Bicakci K, Yavus S. Dramatic response with capecitabine after cranial radiation to the brain parenchymal and leptomeningeal metastases from lung cancer. Eur J Intern Med. 2009;20:96–9.CrossRef Paydas S, Bicakci K, Yavus S. Dramatic response with capecitabine after cranial radiation to the brain parenchymal and leptomeningeal metastases from lung cancer. Eur J Intern Med. 2009;20:96–9.CrossRef
19.
go back to reference Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press; 2010. Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press; 2010.
20.
go back to reference Jass JR, Smith M. Sialic acid and epithelial differentiation in colorectal polyps and cancer—a morphological, mucin and lectin histochemical study. Pathology. 1992;24:233–42.CrossRef Jass JR, Smith M. Sialic acid and epithelial differentiation in colorectal polyps and cancer—a morphological, mucin and lectin histochemical study. Pathology. 1992;24:233–42.CrossRef
21.
go back to reference Mäkinen MJ. Colorectal serrated adenocarcinoma. Histopathology. 2006;50:131–50.CrossRef Mäkinen MJ. Colorectal serrated adenocarcinoma. Histopathology. 2006;50:131–50.CrossRef
22.
go back to reference Lee CT, Huang YC, Hung LY, et al. Serrated adenocarcinoma morphology in colorectal mucinous adenocarcinoma is associated with improved patient survival. Oncotarget. 2017;8:35165–75.CrossRef Lee CT, Huang YC, Hung LY, et al. Serrated adenocarcinoma morphology in colorectal mucinous adenocarcinoma is associated with improved patient survival. Oncotarget. 2017;8:35165–75.CrossRef
Metadata
Title
Neoplastic meningitis due to colorectal cancer
Authors
Kaoru Kidate
Hironori Kobayashi
Katsunari Miyamoto
Yoshihiro Sakashita
Motoki Ninomiya
Yujiro Yokoyama
Yasushi Hashimoto
Kazuhiro Toyota
Fumio Shimamoto
Publication date
01-10-2020

Other articles of this Issue 5/2020

Clinical Journal of Gastroenterology 5/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.